Merck, Ridgeback to supply 1.75 million molnupiravir courses to UK
Molnupiravir is an orally administered form of a potent ribonucleoside analogue that blocks the SARS-CoV-2 replication. It is planned to be sold under the trademark Lagevrio in the UK.
December 24, 2021
by Pharmaceutical-Business-Review
UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours
A new UK-based trial is set to assess the efficacy of GW Pharma’s cannabis-based drug Sativex as a potential treatment for patients with a recurrent glioblastoma – the most aggressive form of brain tumours.
August 6, 2021
by pharmatimes
More than 85 million COVID vaccines administered across the UK, reports DHSC
A total of 85,196,986 doses of a COVID-19 vaccine have been administered in the UK according to the latest figures, with 46,851,145 people receiving a first dose (88.6%) and 38,345,841 people receiving both doses (72.5%).
August 3, 2021
by pharmatimes
India and UK to conduct clinical trials of Ashwagandha for promoting COVID-19 recovery
MoU signed between All India Institute of Ayurveda (under the Ministry of Ayush) and the UK’s London School of Hygiene and Tropical Medicine.
August 3, 2021
by expresspharma
GPs call for rescue plan to ‘save’ general practice in the UK
The Royal College of General Practitioners (RCGP) has called for an emergency rescue package to provide a solution to ‘crisis-torn’ general practice in the UK.
August 2, 2021
by pharmatimes
UK genomics market valued at over £5bn, according to new report
A new report has revealed the strength of the UK’s genomics sector for investors, patients and the UK economy, adding that the sector has a market of over £5bn.
August 2, 2021
by pharmatimes
New study provides insight into the pharma industry’s reputation in the UK
New research from the Association of the British Pharmaceutical Industry (ABPI) and Ipsos MORI reveals attitudes to the pharmaceutical industry in the UK, including perceptions of healthcare professionals (HCPs), the public and members of parliament.
July 30, 2021
by pharmatimes
High Commissioner of India visits Wockhardt UK
The High Commissioner was provided with a tour of the vaccine fill-finish facility which is currently contracted by the UK Government to manufacture the Oxford/AstraZeneca COVID-19 vaccine until August 2022.
July 29, 2021
by expresspharma
UK to launch research studies to develop long Covid therapies
The UK Government has announced plans to commence a research programme comprising of 15 new studies to develop new therapies for long Covid and enhance diagnosis.
July 20, 2021
by pharmaceutical-technology
‘Most comprehensive’ flu vaccination programme in UK history launching for winter 2021
The government has announced that it will launch the ‘most comprehensive’ flu vaccination programme in UK history for winter 2021.
July 19, 2021
by pharmatimes
UK fines pharma companies $360 million for overcharging NHS
The watchdog said the firms charged the NHS "excessively high prices" for almost a decade for the steroid hydrocortisone.
July 16, 2021
by expresspharma
Contraceptive mini pill to be made available over the counter in the UK
The contraceptive pill will be available to buy over the counter at UK pharmacies for the first time after a landmark ruling from the Medicines and Healthcare products Regulatory Agency (MHRA).
July 12, 2021
by pharmaceutical-technology